Vimian Group AB Logo

Vimian Group AB

Global animal health company in pharma, medtech, diagnostics, and vet services.

VIMIAN | ST

Overview

Corporate Details

ISIN(s):
SE0015961982 (+2 more)
LEI:
549300OQ8R5TCAP0BS18
Country:
Sweden
Address:
Riddargatan 19, 114 57 Stockholm

Description

Vimian Group is a global animal health company that applies science and technology to improve animal well-being. The company operates across four main segments: Specialty Pharma, MedTech, Veterinary Services, and Diagnostics. Through its portfolio of businesses, Vimian develops, manufactures, and distributes a wide range of products and services, including pharmaceuticals, medical devices, diagnostic tools, and specialized veterinary care. Its growth strategy combines in-house research and development with the acquisition of innovative companies to expand its offerings for veterinary professionals, clinics, and laboratories.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-30 17:30
Förändring av antalet aktier och röster i Vimian
Swedish 104.4 KB
2025-12-30 17:30
Change in the number of shares and votes in Vimian
English 104.1 KB
2025-12-22 21:30
Vimian har beslutat om nyemission och återköp av ytterligare D-aktier, E1 2025-…
Swedish 110.0 KB
2025-12-22 21:30
Vimian has resolved to issue and repurchase additional class D shares, class E1…
English 109.8 KB
2025-11-28 17:30
Change in the number of shares and votes in Vimian
English 106.5 KB
2025-11-28 17:30
Förändring av antalet aktier och röster i Vimian
Swedish 106.7 KB
2025-11-24 07:15
Vimian Group AB (publ) appoints Alireza Tajbakhsh as CEO
English 111.4 KB
2025-11-24 07:15
Vimian Group AB (publ) utser Alireza Tajbakhsh till vd och koncernchef
Swedish 111.3 KB
2025-10-27 07:00
Vimian has resolved to issue and repurchase class D shares, class E1 2025 share…
English 101.0 KB
2025-10-27 07:00
Vimian har beslutat om nyemission och återköp av D-aktier, E1 2025-aktier, E2 2…
Swedish 101.1 KB
2025-10-22 07:45 Swedish 2.0 MB
2025-10-22 07:45 English 1.9 MB
2025-09-23 10:00
Nomination Committee for Vimian’s 2026 Annual General Meeting
English 97.6 KB
2025-09-23 10:00
Valberedning inför Vimians årsstämma 2026
Swedish 97.6 KB
2025-08-30 01:03
Superior Court of Delaware awards Vimian USD 40.2 million in indemnification di…
English 108.1 KB

Automate Your Workflow. Get a real-time feed of all Vimian Group AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Vimian Group AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Vimian Group AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-02-14 Sven Johan Magnus Göte Kjellberg Other Sell 425,000 19,167,500.00 SEK
2024-12-23 Sven Johan Magnus Göte Kjellberg Other Sell 25,000 1,026,000.00 SEK

Peer Companies

Aprogen, Inc Logo
Develops and manufactures biologic medicines, including biosimilars and novel drugs.
South Korea
007460
Develops drugs for intractable diseases by regulating oxidative stress and CAFs.
South Korea
293780
Aptamer Sciences Inc Logo
Clinical-stage company developing aptamer-based therapeutics for oncology.
South Korea
291650
Aptorum Group Ltd Logo
Clinical-stage biopharma developing therapeutics for oncology and infectious diseases.
United States of America
APM
Aquestive Therapeutics, Inc. Logo
Pharmaceutical company developing oral film medicines for CNS and allergic reactions.
United States of America
AQST
Arbutus Biopharma Corp Logo
Clinical-stage biopharma company developing a functional cure for chronic Hepatitis B.
United States of America
ABUS
Arcellx, Inc. Logo
A clinical-stage biotech company developing immunotherapies for cancer and autoimmune diseases.
United States of America
ACLX
Arctic Bioscience Logo
Develops pharmaceutical and nutraceutical products from marine membrane lipids.
Norway
ABS
ArcticZymes Technologies Logo
Develops and manufactures novel recombinant enzymes from Arctic marine organisms.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
A commercial-stage mRNA medicines company focused on rare and infectious diseases.
United States of America
ARCT

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.